Par Drugs and Chemicals Limited (NSE:PAR)
99.00
-1.51 (-1.50%)
Jun 6, 2025, 3:29 PM IST
Par Drugs and Chemicals Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 275.77 | 366.54 | 222.43 | 162.06 | 211.64 | Upgrade
|
Cash & Short-Term Investments | 275.77 | 366.54 | 222.43 | 162.06 | 211.64 | Upgrade
|
Cash Growth | -24.76% | 64.79% | 37.25% | -23.42% | 186.81% | Upgrade
|
Accounts Receivable | 167.14 | 137.14 | 169.69 | 184.67 | 124.51 | Upgrade
|
Other Receivables | 42.44 | - | - | 0.74 | 1.37 | Upgrade
|
Receivables | 210.57 | 138.09 | 170.45 | 185.91 | 126.19 | Upgrade
|
Inventory | 61.06 | 44.21 | 59.68 | 54.98 | 38.9 | Upgrade
|
Prepaid Expenses | - | 0.37 | 0.43 | 0.48 | 0.55 | Upgrade
|
Other Current Assets | 1.21 | 47.03 | 41.38 | 32.2 | 34.57 | Upgrade
|
Total Current Assets | 548.61 | 596.24 | 494.37 | 435.64 | 411.86 | Upgrade
|
Property, Plant & Equipment | 389.15 | 413.35 | 386.95 | 343.51 | 344.3 | Upgrade
|
Long-Term Investments | 250.7 | 0.12 | 0.1 | 0.1 | 0.1 | Upgrade
|
Other Long-Term Assets | 5.44 | 6.41 | 7.26 | 7.65 | 7.58 | Upgrade
|
Total Assets | 1,194 | 1,016 | 888.68 | 786.9 | 763.84 | Upgrade
|
Accounts Payable | 108.91 | 53.56 | 80.92 | 106.62 | 67.18 | Upgrade
|
Accrued Expenses | - | 21 | 20.4 | 8.41 | 19.71 | Upgrade
|
Short-Term Debt | - | - | - | - | 32.48 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | 6.82 | Upgrade
|
Current Income Taxes Payable | - | 49.76 | 37.95 | 33.45 | 33.61 | Upgrade
|
Current Unearned Revenue | - | 0.05 | 0.62 | 0.09 | - | Upgrade
|
Other Current Liabilities | 56.77 | 0.02 | 0 | 0 | 0.01 | Upgrade
|
Total Current Liabilities | 165.69 | 124.39 | 139.89 | 148.57 | 159.79 | Upgrade
|
Long-Term Debt | - | - | - | - | 43.92 | Upgrade
|
Long-Term Deferred Tax Liabilities | 35.8 | 35.4 | 35 | 35.5 | 34.05 | Upgrade
|
Other Long-Term Liabilities | 0 | - | - | - | - | Upgrade
|
Total Liabilities | 204.15 | 159.79 | 176.3 | 188.13 | 241.7 | Upgrade
|
Common Stock | 123.05 | 123.05 | 123.05 | 123.05 | 61.52 | Upgrade
|
Additional Paid-In Capital | - | 106.73 | 106.73 | 106.73 | 168.25 | Upgrade
|
Retained Earnings | - | 625.86 | 481.93 | 368.31 | 291.69 | Upgrade
|
Comprehensive Income & Other | 866.7 | 0.69 | 0.69 | 0.69 | 0.69 | Upgrade
|
Total Common Equity | 989.75 | 856.32 | 712.38 | 598.77 | 522.15 | Upgrade
|
Shareholders' Equity | 989.75 | 856.32 | 712.38 | 598.77 | 522.15 | Upgrade
|
Total Liabilities & Equity | 1,194 | 1,016 | 888.68 | 786.9 | 763.84 | Upgrade
|
Total Debt | - | - | - | - | 83.21 | Upgrade
|
Net Cash (Debt) | 275.77 | 366.54 | 222.43 | 162.06 | 128.43 | Upgrade
|
Net Cash Growth | -24.76% | 64.79% | 37.25% | 26.19% | 839.12% | Upgrade
|
Net Cash Per Share | 22.42 | 29.79 | 18.08 | 13.17 | 10.44 | Upgrade
|
Filing Date Shares Outstanding | 12.32 | 12.3 | 12.3 | 12.3 | 12.3 | Upgrade
|
Total Common Shares Outstanding | 12.32 | 12.3 | 12.3 | 12.3 | 12.3 | Upgrade
|
Working Capital | 382.93 | 471.85 | 354.48 | 287.07 | 252.06 | Upgrade
|
Book Value Per Share | 80.33 | 69.59 | 57.90 | 48.66 | 42.43 | Upgrade
|
Tangible Book Value | 989.75 | 856.32 | 712.38 | 598.77 | 522.15 | Upgrade
|
Tangible Book Value Per Share | 80.33 | 69.59 | 57.90 | 48.66 | 42.43 | Upgrade
|
Land | - | 31.48 | 6.21 | 3.32 | 3.32 | Upgrade
|
Buildings | - | 198.21 | 183.18 | 152.36 | 138.89 | Upgrade
|
Machinery | - | 459.94 | 443.59 | 413.09 | 355.88 | Upgrade
|
Construction In Progress | - | 0.25 | 2.45 | 2.48 | 45.22 | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.